Effectable application of vascular endothelial growth factor to critical sized rat calvaria defects

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 2, 2010, Pages 225-231

  Yonamine, Yutaka ^a   Matsuyama, Takashi ^a   Sonomura, Takahiro ^a   Takeuchi, Hironobu ^a   Furuichi, Yasushi ^b   Uemura, Masanori ^a   Izumi, Yuichi ^c,d   Noguchi, Kazuyuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RECOMBINANT PROTEIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BONE REGENERATION; DRUG EFFECT; KINETICS; MALE; METHODOLOGY; RAT; SCANNING ELECTRON MICROSCOPY; SKULL; TISSUE REGENERATION; WISTAR RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; GUIDED TISSUE REGENERATION; KINETICS; LACTIC ACID; MALE; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SKULL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74149094039     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.09.010     Document Type: Article

References (29)

1. Kneser U., Schaefer D.J., Polykandriotis E., and Horch R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10 (2006) 7-19
2. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., and Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 428 (2004) 138-139
3. Kanczler J.M., and Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15 (2008) 100-114
4. Eastlund T. Infectious disease transmission through cell, tissue, and organ \ transplantation: reducing the risk through donor selection. Cell Transplant 4 (1995) 455-477
5. Tanaka J., Asaka M., and Imamura M. T-Cell co-signalling molecules in graft-versus-host disease. Ann Hematol 79 (2000) 283-290
6. Simion M., Dahlin C., Rocchietta I., Stavropoulos A., Sanchez R., and Karring T. Vertical ridge augmentation with guided bone regeneration in association with dental implants: an experimental study in dogs. Clin Oral Implants Res 18 (2007) 86-94
7. Simion M., Rocchietta I., and Dellavia C. Three-dimensional ridge augmentation with xenograft and recombinant human platelet-derived growth factor-BB in humans: report of two cases. Int J Periodontics Restorative Dent 27 (2007) 109-115
8. Marks T., Wingerter S., Franklin L., Woodall Jr. J., Tucci M., Russell G., et al. Histological and radiographic comparison of allograft substitutes using a continuous delivery model in segmental defects. Biomed Sci Instrum 43 (2007) 194-199
9. King T.W., Brey E.M., Youssef A.A., Johnston C., and Patrick Jr. C.W. Quantification of vascular density using a semiautomated technique for immunostained specimens. Anal Quant Cytol Histol 24 (2002) 39-48
10. Carano R.A., and Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 8 (2003) 980-989
11. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20 (2005) 2028-2035
12. Sandor G.K., and Suuronen R. Combining adipose-derived stem cells, resorbable scaffolds and growth factors: an overview of tissue engineering. J Can Dent Assoc 74 (2008) 167-170
13. Granero-Molto F., Weis J.A., Longobardi L., and Spagnoli A. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 8 (2008) 255-268
14. Elsalanty M.E., Por Y.C., Genecov D.G., Salyer K.E., Wang Q., Barcelo C.R., et al. Recombinant human BMP-2 enhances the effects of materials used for reconstruction of large cranial defects. J Oral Maxillofac Surg 66 (2008) 277-285
15. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H.P., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 41 (2007) 247-255
16. Buser D., Dula K., Hirt H.P., and Schenk R.K. Lateral ridge augmentation using autografts and barrier membranes: a clinical study with 40 partially edentulous patients. J Oral Maxillofac Surg 54 (1996) 420-432 discussion 32-3
17. Hermann J.S., and Buser D. Guided bone regeneration for dental implants. Curr Opin Periodontol 3 (1996) 168-177
18. Buser D., Dula K., Belser U.C., Hirt H.P., and Berthold H. Localized ridge augmentation using guided bone regeneration. II. Surgical procedure in the mandible. Int J Periodontics Restorative Dent 15 (1995) 10-29
19. Dies F., Etienne D., Abboud N.B., and Ouhayoun J.P. Bone regeneration in extraction sites after immediate placement of an e-PTFE membrane with or without a biomaterial. A report on 12 consecutive cases. Clin Oral Implants Res 7 (1996) 277-285
20. Geurs N.C., Korostoff J.M., Vassilopoulos P.J., Kang T.H., Jeffcoat M., Kellar R., et al. Clinical and histologic assessment of lateral alveolar ridge augmentation using a synthetic long-term bioabsorbable membrane and an allograft. J Periodontol 79 (2008) 1133-1140
21. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., and Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 8 (1991) 713-720
22. Kim T.K., and Burgess D.J. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol 54 (2002) 897-905
23. Peters M.C., Polverini P.J., and Mooney D.J. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 60 (2002) 668-678
24. Cleland J.L., Duenas E.T., Park A., Daugherty A., Kahn J., Kowalski J., et al. Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 72 (2001) 13-24
25. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Gunther K.P., Dehio C., et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30 (2002) 472-477
26. Fiedler J., Leucht F., Waltenberger J., Dehio C., and Brenner R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334 (2005) 561-568
27. Kaigler D., Wang Z., Horger K., Mooney D.J., and Krebsbach P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21 (2006) 735-744
28. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E., and Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43 (2008) 931-940
29. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20 (2005) 2017-2027